Logo image of 703.DE

ALFEN N.V. (703.DE) Stock Fundamental Analysis

FRA:703 - NL0012817175 - Common Stock

9.212 EUR
-0.2 (-2.1%)
Last: 9/9/2025, 7:00:00 PM
Fundamental Rating

4

Overall 703 gets a fundamental rating of 4 out of 10. We evaluated 703 against 58 industry peers in the Electrical Equipment industry. While 703 seems to be doing ok healthwise, there are quite some concerns on its profitability. 703 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 703 has reported negative net income.
703 had a positive operating cash flow in the past year.
Of the past 5 years 703 4 years were profitable.
In the past 5 years 703 always reported a positive cash flow from operatings.
703.DE Yearly Net Income VS EBIT VS OCF VS FCF703.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

703's Return On Assets of -5.09% is on the low side compared to the rest of the industry. 703 is outperformed by 63.79% of its industry peers.
The Return On Equity of 703 (-11.40%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
703.DE Yearly ROA, ROE, ROIC703.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

Looking at the Gross Margin, with a value of 34.60%, 703 is in line with its industry, outperforming 46.55% of the companies in the same industry.
703's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 703 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
703.DE Yearly Profit, Operating, Gross Margins703.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

703 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 703 has about the same amount of shares outstanding.
703 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 703 has been reduced compared to a year ago.
703.DE Yearly Shares Outstanding703.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
703.DE Yearly Total Debt VS Total Assets703.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

703 has an Altman-Z score of 2.57. This is not the best score and indicates that 703 is in the grey zone with still only limited risk for bankruptcy at the moment.
703's Altman-Z score of 2.57 is fine compared to the rest of the industry. 703 outperforms 70.69% of its industry peers.
703 has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
703 has a better Debt to FCF ratio (0.99) than 91.38% of its industry peers.
703 has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
703 has a Debt to Equity ratio of 0.26. This is in the better half of the industry: 703 outperforms 67.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Altman-Z 2.57
ROIC/WACCN/A
WACC6.82%
703.DE Yearly LT Debt VS Equity VS FCF703.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

703 has a Current Ratio of 1.75. This is a normal value and indicates that 703 is financially healthy and should not expect problems in meeting its short term obligations.
703 has a better Current ratio (1.75) than 60.34% of its industry peers.
A Quick Ratio of 1.09 indicates that 703 should not have too much problems paying its short term obligations.
703's Quick ratio of 1.09 is fine compared to the rest of the industry. 703 outperforms 60.34% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.09
703.DE Yearly Current Assets VS Current Liabilites703.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

703 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -287.72%.
Looking at the last year, 703 shows a very negative growth in Revenue. The Revenue has decreased by -13.84% in the last year.
The Revenue has been growing by 27.79% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%

3.2 Future

Based on estimates for the next years, 703 will show a very strong growth in Earnings Per Share. The EPS will grow by 39.12% on average per year.
703 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.80% yearly.
EPS Next Y120.28%
EPS Next 2Y113.81%
EPS Next 3Y82.04%
EPS Next 5Y39.12%
Revenue Next Year-3.79%
Revenue Next 2Y0.99%
Revenue Next 3Y3.19%
Revenue Next 5Y2.8%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
703.DE Yearly Revenue VS Estimates703.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
703.DE Yearly EPS VS Estimates703.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

703 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 22.44, 703 is valued on the expensive side.
The rest of the industry has a similar Price/Forward Earnings ratio as 703.
When comparing the Price/Forward Earnings ratio of 703 to the average of the S&P500 Index (22.59), we can say 703 is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 22.44
703.DE Price Earnings VS Forward Price Earnings703.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as 703.
96.55% of the companies in the same industry are more expensive than 703, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.03
EV/EBITDA 25.34
703.DE Per share data703.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

703's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
703's earnings are expected to grow with 82.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y113.81%
EPS Next 3Y82.04%

0

5. Dividend

5.1 Amount

No dividends for 703!.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

FRA:703 (9/9/2025, 7:00:00 PM)

9.212

-0.2 (-2.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-04 2025-11-04
Inst Owners40.9%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap200.36M
Analysts41.18
Price Target10.86 (17.89%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.14%
PT rev (3m)-33.8%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-95.25%
EPS NY rev (3m)-95.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 22.44
P/S 0.44
P/FCF 4.03
P/OCF 3.08
P/B 1.32
P/tB 1.65
EV/EBITDA 25.34
EPS(TTM)-0.79
EYN/A
EPS(NY)0.41
Fwd EY4.46%
FCF(TTM)2.28
FCFY24.78%
OCF(TTM)2.99
OCFY32.44%
SpS20.85
BVpS6.96
TBVpS5.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.6%
FCFM 10.95%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Debt/EBITDA 4.36
Cap/Depr 56.5%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion 709.26%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.09
Altman-Z 2.57
F-Score5
WACC6.82%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
EPS Next Y120.28%
EPS Next 2Y113.81%
EPS Next 3Y82.04%
EPS Next 5Y39.12%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%
Revenue Next Year-3.79%
Revenue Next 2Y0.99%
Revenue Next 3Y3.19%
Revenue Next 5Y2.8%
EBIT growth 1Y-211.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year726.38%
EBIT Next 3Y136.35%
EBIT Next 5Y65.53%
FCF growth 1Y164.76%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y242.64%
OCF growth 3Y74.32%
OCF growth 5Y31.69%